South & Central America Sepsis Diagnostics Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology [Molecular Diagnostics (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarrays), Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

No. of Pages: 183
Report Code: BMIRE00028086
Category: Life Sciences
South & Central America Sepsis Diagnostics Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. South & Central America Sepsis Diagnostics Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. South & Central America Sepsis Diagnostics Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. South & Central America Sepsis Diagnostics Market Regional Analysis

6.2 South & Central America Sepsis Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 South & Central America Sepsis Diagnostics Market Forecast Analysis

7. South & Central America Sepsis Diagnostics Market Analysis – by Product

7.1 Instruments
  • 7.1.1 Overview
  • 7.1.2 Instruments: South & Central America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Reagents and Assays
  • 7.2.1 Overview
  • 7.2.2 Reagents and Assays: South & Central America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Blood Culture Media
  • 7.3.1 Overview
  • 7.3.2 Blood Culture Media: South & Central America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Software
  • 7.4.1 Overview
  • 7.4.2 Software: South & Central America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. South & Central America Sepsis Diagnostics Market Analysis – by Technology

8.1 Molecular Diagnostics
  • 8.1.1 Overview
  • 8.1.2 Molecular Diagnostics: South & Central America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Flow Cytometry
  • 8.2.1 Overview
  • 8.2.2 Flow Cytometry: South & Central America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Microfluidics
  • 8.3.1 Overview
  • 8.3.2 Microfluidics: South & Central America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Immunoassay
  • 8.4.1 Overview
  • 8.4.2 Immunoassay: South & Central America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Biomarkers
  • 8.5.1 Overview
  • 8.5.2 Biomarkers: South & Central America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.6 Microbiology
  • 8.6.1 Overview
  • 8.6.2 Microbiology: South & Central America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. South & Central America Sepsis Diagnostics Market Analysis – by Method

9.1 Automated Diagnostics and Conventional Diagnostics
  • 9.1.1 Overview
  • 9.1.2 Automated Diagnostics and Conventional Diagnostics: South & Central America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. South & Central America Sepsis Diagnostics Market Analysis – by Test Type

10.1 Point-of-Care Tests and Laboratory Tests
  • 10.1.1 Overview
  • 10.1.2 Point-of-Care Tests and Laboratory Tests: South & Central America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. South & Central America Sepsis Diagnostics Market – South and Central America Analysis

11.1 Overview

11.2 South and Central America
  • 11.2.1 South & Central America Sepsis Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 11.2.1.1 South & Central America Sepsis Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 Brazil: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.1.1 Brazil: South & Central America Sepsis Diagnostics Market Breakdown, by Product
    • 11.2.1.1.2 Brazil: South & Central America Sepsis Diagnostics Market Breakdown, by Technology
    • 11.2.1.1.3 Brazil: South & Central America Sepsis Diagnostics Market Breakdown, by Method
    • 11.2.1.1.4 Brazil: South & Central America Sepsis Diagnostics Market Breakdown, by Test Type
  • 11.2.1.2 Argentina: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.2.1 Argentina: South & Central America Sepsis Diagnostics Market Breakdown, by Product
    • 11.2.1.2.2 Argentina: South & Central America Sepsis Diagnostics Market Breakdown, by Technology
    • 11.2.1.2.3 Argentina: South & Central America Sepsis Diagnostics Market Breakdown, by Method
    • 11.2.1.2.4 Argentina: South & Central America Sepsis Diagnostics Market Breakdown, by Test Type
  • 11.2.1.3 Rest of South and Central America : South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.3.1 Rest of South and Central America : South & Central America Sepsis Diagnostics Market Breakdown, by Product
    • 11.2.1.3.2 Rest of South and Central America : South & Central America Sepsis Diagnostics Market Breakdown, by Technology
    • 11.2.1.3.3 Rest of South and Central America : South & Central America Sepsis Diagnostics Market Breakdown, by Method
    • 11.2.1.3.4 Rest of South and Central America : South & Central America Sepsis Diagnostics Market Breakdown, by Test Type

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 Abbott
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 BD
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 bioMerieux SA
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 Danaher (Beckman Coulter)
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 F. HOFFMANN-LA ROCHE LTD.
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 THERMO FISHER SCIENTIFIC INC.
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - South & Central America Sepsis Diagnostics Market

  • Abbott
  • BD
  • bioMerieux SA
  • Danaher (Beckman Coulter)
  • F. HOFFMANN-LA ROCHE LTD.
  • THERMO FISHER SCIENTIFIC INC.
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)